InsidersTradesSigma
Explore the complete record of transactions filed by Cherington Charles, Director. Insider active across 1 companies, notably Brooklyn ImmunoTherapeutics, Inc.. Aggregated, 4 filings have been published. Total volume traded: €5.2m. The latest transaction was disclosed on 1 June 2021 (J). Regulator: SEC (Form 4). The full history is accessible without signup.
4 of 4 declarations
Charles Cherington is a Director at Brooklyn ImmunoTherapeutics, Inc. He plays a key role in the governance and strategy of the company. Brooklyn ImmunoTherapeutics is a biopharmaceutical company focused on developing immunological treatments. Charles brings valuable expertise in the field, contributing to the company's direction and growth.